Skip to main content

Global 4K Medical Imaging Market Expected to Grow at a CAGR of 12.2% by 2030

 The global 4K medical imaging market was valued at $822.1 million in 2019 and is anticipated to reach $2,399.9 million by 2030, growing at a CAGR of 12.2% during the forecast period 2020-2030.




The increasing demand for superior visualization quality for medical field, and availability of technologically advanced products in the field of high-definition medical imaging, and the increasing incidences of chronic health conditions have driven the growth of the global 4K medical imaging market, huge R&D investments, among others, are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting market growth. These challenges include the physicians’ reluctance toward the adoption of advanced technologies such as 4K imaging. Hence, it is anticipated that these trends will have a significant impact on the 4K medical imaging market in the next five years, and the market will grow multifold.

The emergence of 4K technologies is becoming more commonplace in the healthcare sector. With the introduction and technological advancements in the current offerings, 4K medical imaging is now entering the operating room (OR). As per the industry definition, the term 4K technologies is generally referred to as imaging and visualization technologies with a horizontal resolution on the order of XX pixels, resulting in four times the resolution of high definition (HD).

In the OR, a shift can be seen toward minimally invasive surgery (MIS) in many routine procedures. There are some evident benefits for patients from these types of surgery, such as less blood loss, small incision size, shorter hospital stay, and enhanced procedure accuracy, among others. However, to an extent, surgeons are subjected to limited vision, majorly because of their reliance on laparoscopic cameras. In the modern era of surgical imaging applications, there are many benefits of the extra resolution. Fine structures that are captured with 4K cameras can be identified with greater precision, offering surgeons a clearer picture during open surgery or minimally invasive procedures. Moreover, 4K technologies are advantageous as it primarily offers extensive detailing in images that give clinicians or surgeons a greater viewing option during a surgical procedure. Images captured at 4K resolution with a surgical endoscope can be cropped or zoomed for a close-up view while maintaining their full HD resolution. In addition, a single 4K monitor can ‘tile’ multiple images from surgical cameras, vital signs, and other sources, providing an informative overview for surgeons and OR staff


The Market Drivers for the 4K Medical Imaging Market are

•    Increasing Demand for Superior Visualization Quality for Medical Field

•    Advantages of 4K Ultra High Definition Over Full High Definition

•    Availability of Technological Advanced Products in the Field of High-Definition Medical Imaging

Market Opportunities

•    Development of 8K Imaging Modalities

•    Slim and Flexible Design for Space Saving

Market Challenges

•    High Capital Cost

•    Requirement of Greater Bandwidth Connectivity

•    Increasing Adoption of Refurbished Medical Displays

Most of the manufacturers in the market are incorporating collaborations and partnerships with not only other companies but also the university and research institutions as the key strategies to develop novel 4K medical imaging systems and attain a strong financial position in the market.

Moreover, the leading imaging modality providers in the global 4K medical imaging market include Olympus Corporation, Siemens Healthineers AG., Sony Corporation, B. Braun Melsungen AG, Eizo Corporation, LG Corporation, Stryker Corporation, Innolux Corporation, Medtronic plc Carl Zeiss, Braco N.V., Leica Microsystems (Danaher Corporation), Sharp NEC Display Solutions, Ltd., Ikegami Tsushinki, and Zimmer Biomet, among others.

Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...